A clinical study to evaluate the effectiveness of Pichumardadi Lepa along with Aranal in the management of Dadru (Dermatophytosis).

Randomised controlled clinical study to to evaluate the efficacy of Pichumardadi lepa along with Aranal in the treatment of Dadru with special reference to Dermatophytosis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/097454

Enrollment

Registered

2025-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 60 yrs Sex All genders Patients with sign and symptoms like Kandu, Pidaka, Valvarmy a maindala. Understanding and being willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: Patients, having skin disease other than Dadru Kushtha like Eczema, Psoriasis, Urticaria etc. Pregnancy and lactating mother Immune-compromised patients like AIDS (HIV Positive) HbsAg Positive etc. Person with severe disorder likes CA Liver, disorder, renal or cardiac problems, bed ridden, due to chronic illness. Patient taking other antifungal drugs in between treatment Patient having adverse effect.

Design outcomes

Primary

Measure	Time frame
reduction in grades of symptompsTimepoint: 3 weeks	—

Secondary

Measure	Time frame
reduction of number of mandalaTimepoint: 3 weeks	—

Countries

India

Contacts

Public ContactDr Meenakshi Subhash Rewdkar Kole

R A Podar Ayurvedic Medical College,Worli

drmrevadkar@yahoo.com9757476325

Outcome results